EX-99.1 2 v114703_ex99-1.htm
 
Mark Murphy, Chief Executive Officer
 
(949) 769-3200
   
 
Jeff Stanlis, Investor Relations
 
Hayden Communications, Inc.
 
(602) 476-1821

For Immediate Release      

PRO-DEX, INC. ANNOUNCES THIRD QUARTER 2008 RESULTS

Sales increase 29% to $7.6 million for the quarter
Company completes relocation of its Santa Ana facility to Irvine

IRVINE, CA, May 15, 2008 - PRO-DEX, INC. (NASDAQ: PDEX) today announced financial results for the third fiscal quarter and nine-month period for fiscal 2008, the periods ending March 31, 2008.

Consolidated net sales for the third quarter increased 29% to $7.6 million compared to $5.9 million reported for the third quarter of fiscal 2007. For the nine months ended March 31, 2008, consolidated net sales increased 25% to a $19.7 million compared to $15.8 million for the year ago period.

Net income for the third quarter was $99,000 or $0.01 per basic and diluted share (based on 9.7 and 9.9 million shares, respectively) compared to net income of $216,000 or $0.02 per share on a basic and diluted basis for the three months ended March 31, 2007 (based on 9.6 and 9.8 million shares, respectively). The Company reported net income for the first nine months of $729,000 or $0.08 per share on a basic and $0.07 per share on a diluted basis (based on 9.7 and 9.9 million shares, respectively) compared to net income of $319,000, or $0.03 per basic and fully diluted share (based on 9.5 and 9.8 million shares, respectively) for the first nine months last year.

Mark P. Murphy, the Company’s President and Chief Executive Officer, commented, “We are pleased to report strong sales this quarter. This strength was attributable to high shipments to two large customers, meeting spikes in their demand. Shipments to these customers have now returned to normal levels, so we expect that our near-term sales will be more in line with previous quarters. The spike provided us with an opportunity to prove the scalability of our manufacturing capabilities. Our sales growth has all come from our medical device business, more than offsetting softness in other markets. We remained profitable, despite a change in the method of determining our inventory reserve, which resulted in a one-time impact of approximately $300,000. Without the change, we would have reported $0.02 higher earnings per share in the quarter.

Consolidated gross profit for the quarter ended March 31, 2008 increased 3% over the same quarter in the previous year to $2.2 million, a 29% gross profit margin, compared to gross profit of $2.1 million, or 36% gross profit margin last year. Gross profit margins were reduced by the change in inventory reserve method, a change in sales mix shift away from software-related industrial sales to medical sales, and higher warranty costs due to a higher percentage of sales of warranty-related products. Gross profit for the nine months were $6.7 million, or 34% gross profit margin compared to gross profit of $5.5 million or 35% gross profit margin for the year-ago period. The change in inventory reserve calculation method reduced gross profit margins by approximately 4 margin points in the third quarter and 1.5 margin points year to date. These reductions were slightly offset by efficiency gains due to the higher sales levels in 2008.

Third quarter operating expenses increased by 12% to $2.0 million, compared to $1.8 million in the third quarter last year, but as a percentage of sales, was reduced from 30% to 26%. For the nine months, operating expense increased 9% to $5.5 million from $5.0 million in the year-ago period, but as a percentage of sales, was reduced from 32% to 28%.
 
Mr. Murphy continued, “We completed the move into our new Irvine facility in late April. The move occurred according to our plan and we have now resumed normal operations. We incurred approximately $13,000 in non-recurring expenses related to this relocation during the third quarter and expect the bulk of such move related expenses approximating $500,000 (including out-of-pocket and inefficiency costs) to be realized in Q4.

 
 

 

The Company completed the March 31, 2008 quarter with cash and cash equivalents of $529,000 compared to cash and cash equivalents of $403,000 as of June 30, 2007. Total working capital was $5.7 million as of March 31, 2008. There was $500,000 borrowed under the terms of the Company’s credit line compared to $300,000 at June 30, 2007 and nothing borrowed against the Company’s $2 million term commitment facility, leaving the total eligible additional borrowing capacity as of March 31, 2008 at $5.5 million. Net debt (total debt less cash) was $2.1 million at March 31, 2008, reduced from $2.4 million at June 30, 2007. Shareholders’ equity increased 6.3% to $13.7 million from $12.9 million as of June 30, 2007.

Teleconference Information:

Investors and all others are invited to listen to a conference call discussing the third fiscal quarter 2008 results, today at 4:30 p.m. Eastern Time. The call is scheduled to be broadcast live over the Internet and may be accessed by visiting the Company's website at http://www.pro-dex.com. Mark Murphy, Chief Executive Officer and Jeff Ritchey, Chief Financial Officer, plan to host the call. If you would like to join the call, dial (866) 323-3543 U.S. and (706) 679-0672 International, conference I.D. 46906033. You may identify the call as the Pro-Dex Third Quarter Earnings Call. An online archive of the broadcast will be available within one hour of the completion of the call and will be accessible on the Company's website for 30 days. Additionally, a telephone replay will be available 2 hours after the call for 48 hours by dialing (800) 642-1687 U.S. or (706) 645-9291 for international callers, conference I.D. number 46906033.

Pro-Dex Inc., with operations in Irvine, California, Beaverton, Oregon and Carson City, Nevada, specializes in bringing speed to market in the development and manufacture of technology-based solutions that incorporate embedded motion control, miniature rotary drive systems and fractional horsepower DC motors, serving the medical, dental, semi-conductor, scientific research and aerospace markets. Pro-Dex's products are found in hospitals, dental offices, medical engineering labs, scientific research facilities, commercial and military aircraft, and high tech manufacturing operations globally.

For more information, visit the Company's website at www.pro-dex.com.

Statements herein concerning the Company's plans, growth and strategies may include 'forward-looking statements' within the context of the federal securities laws. Statements regarding the Company's future events, developments and future performance, as well as management's expectations, beliefs, plans, estimates or projections relating to the future, are forward-looking statements within the meaning of these laws. The Company's actual results may differ materially from those suggested as a result of various factors. Interested parties should refer to the disclosure concerning the operational and business concerns of the Company set forth in the Company's filings with the Securities and Exchange Commission.
 
(tables follow)

 
2

 

PRO-DEX, INC. and SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS

   
March 31, 2008(unaudited)
 
June 30,2007
(audited)
 
ASSETS
             
Current assets:
             
Cash and cash equivalents
 
$
529,000
 
$
403,000
 
Accounts receivable, net of allowance for doubtful accounts of $140,000 at March 31, 2008 and $153,000 at June 30, 2007
   
3,497,000
   
3,436,000
 
Inventories, net
   
4,713,000
   
4,622,000
 
Prepaid expenses
   
452,000
   
205,000
 
Deferred income taxes
   
1,049,000
   
1,091,000
 
Total current assets
   
10,240,000
   
9,757,000
 
 
             
Property, plant, equipment and leasehold improvements, net
   
5,286,000
   
3,778,000
 
Other assets:
             
Goodwill
   
2,997,000
   
2,997,000
 
Intangibles - Patents, net
   
1,246,000
   
1,321,000
 
Deferred income taxes
   
229,000
   
229,000
 
Other
   
34,000
   
25,000
 
Total other assets
   
4,506,000
   
4,572,000
 
     
     
   
 
 
Total assets
 
$
20,032,000
 
$
18,107,000
 
               
LIABILITIES AND SHAREHOLDERS' EQUITY
             
Current liabilities:
             
Credit Line
 
$
500,000
 
$
300,000
 
Accounts payable
   
1,952,000
   
1,110,000
 
Accrued expenses
   
1,703,000
   
1,183,000
 
Income taxes payable
   
114,000
   
158,000
 
Current portion of term note
   
250,000
   
250,000
 
Current portion of real estate loan
   
30,000
   
26,000
 
Current portion of "patent" deferred payable
   
-
   
82,000
 
Total current liabilities
   
4,549,000
   
3,109,000
 
               
Long-term liabilities
             
Term note
   
208,000
   
396,000
 
Real estate loan
   
1,568,000
   
1,593,000
 
Patent deferred payable
   
45,000
   
158,000
 
Total long-term liabilities
   
1,821,000
   
2,147,000
 
Total liabilities
   
6,370,000
   
5,256,000
 
Commitments and contingencies
             
Shareholders' equity:
             
Common shares; no par value; 50,000,000 shares authorized; 9,718,366 shares issued and outstanding March 31, 2008, 9,718,366 shares issued and outstanding June 30, 2007,
   
16,497,000
   
16,340,000
 
Accumulated deficit
   
(2,835,000
)
 
(3,489,000
)
               
Total shareholders’ equity
   
13,662,000
   
12,851,000
 
     
 
   
 
 
Total liabilities and shareholders’ equity
 
$
20,032,000
 
$
18,107,000
 

 
3

 

PRO-DEX, INC. and SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS
Three months ended March 31 (unaudited)

   
2008
 
2007
 
           
Net sales
 
$
7,614,000
 
$
5,916,000
 
               
Cost of sales
   
5,388,000
   
3,760,000
 
Gross profit
   
2,226,000
   
2,156,000
 
               
Operating expenses:
             
Selling
   
397,000
   
361,000
 
General and administrative expenses
   
892,000
   
780,000
 
Research and development costs
   
729,000
   
664,000
 
Total operating expenses
   
2,018,000
   
1,805,000
 
                   
Income from operations
   
208,000
   
351,000
 
               
Other income (expense):
             
Other expense, net
   
(45,000
)
 
(4,000
)
Royalty income
   
5,000
   
5,000
 
Interest expense
   
(37,000
)
 
(66,000
)
Total
   
(77,000
)
 
(65,000
)
               
Income before provision for income taxes
   
131,000
   
286,000
 
               
Provision for income taxes
   
32,000
   
70,000
 
Net income
 
$
99,000
 
$
216,000
 
               
Net income per share:
                   
Basic
 
$
0.01
 
$
0.02
 
Diluted
 
$
0.01
 
$
0.02
 
               
Weighted average shares outstanding - basic
   
9,718,366
   
9,556,272
 
Weighted average shares outstanding - diluted
   
9,935,358
   
9,765,033
 

 
4

 

PRO-DEX, INC. and SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS
Nine months ended March 31 (unaudited)

   
2008
 
2007
 
           
Net sales
 
$
19,728,000
 
$
15,780,000
 
               
Cost of sales
   
12,996,000
   
10,274,000
 
Gross profit
   
6,732,000
   
5,506,000
 
               
Operating expenses:
             
Selling
   
1,072,000
   
1,039,000
 
General and administrative expenses
   
2,492,000
   
2,106,000
 
Research and development costs
   
1,939,000
   
1,890,000
 
Total operating expenses
   
5,503,000
   
5,035,000
 
                       
Income from operations
   
1,229,000
   
471,000
 
               
Other income (expense):
             
Other income, net
   
3,000
   
7,000
 
Royalty income
   
25,000
   
30,000
 
Interest expense, net
   
(119,000
)
 
(179,000
)
Total
   
(91,000
)
 
(142,000
)
               
Income before provision for income taxes
   
1,138,000
   
329,000
 
               
Provision for income taxes
   
409,000
   
10,000
 
Net income
 
$
729,000
 
$
319,000
 
               
Net Income per share:
             
Basic
 
$
0.08
 
$
0.03
 
Diluted
 
$
0.07
 
$
0.03
 
               
Weighted average shares outstanding - basic
   
9,718,366
   
9,549,211
 
Weighted average shares outstanding - diluted
   
9,928,128
   
9,768,277
 

 
5